ÃâÒß´úлÐÔ¼²²¡°üÀ¨·Ç¾Æ¾«ÐÔÖ¬·¾ÐÔ¸ÎÑ×£¨NASH£©¡¢ÌÇÄò²¡ºÍ·ÊÅֵȡ£¡£¡£·Ç¾Æ¾«ÐÔÖ¬·¾¸Î£¨NAFLD£©Ó°ÏìÌìÏÂÔ¼1/4µÄ³ÉÄêÈË£¬£¬NASHÊÇÆäÖÐÒ»ÖÖ½ÏÖØµÄÑÇÐÍ£¬£¬²¿·Ö²¡ÈË»áÏ£ÍûÖÁ¸ÎÓ²»¯ºÍ¸Î°©£¬£¬ÓÖÓëÆäËû´úлÔÓÂÒÈçÒȵºËØ·´¿¹ºÍ¸ß֬Ѫ֢Ç×½üÏà¹Ø¡£¡£¡£
¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºËÕÊ¿³É½ÌÊÚÍŶÓÕ¹ÏÖÁËÏßÁ£Ìå»·×´RNAµ÷¿Ø¸ÎÔàÃâÒß´úлÐÔÑ×֢лúÖÆ£¬£¬Ñо¿Ð§¹ûÓÚ2020Äê9ÔÂ14ÈÕÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯Cell½ÒÏþ£¬£¬ÌâΪ¡°Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output¡±¡£¡£¡£ËïÒÝÏɼÍÄîÒ½ÔºËÕÊ¿³É½ÌÊÚ¡¢Á¥ÊôµÚÈýÒ½Ôº¸ßÖ¾Á¼½ÌÊÚºÍËïÒÝÏɼÍÄîÒ½ÔºÐíС¶¡½ÌÊÚÊDZ¾ÂÛÎĵÄÅäºÏͨѶ×÷Õߣ¬£¬ËïÒÝÏɼÍÄîÒ½ÔºÔº³¤ËζûÎÀԺʿΪÑо¿ÌṩÁËÃû¹óµÄÒâ¼û¡£¡£¡£ÕÔç²Ò㸱Ñо¿Ô±¡¢µËºéÖ÷ÈÎҽʦ¡¢Áõ¼ÎìÏÖúÀíÑо¿Ô±¡¢ÂíÈðÓ±Ñо¿ÉúΪ¸ÃÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£¡£
ÔÚ¹ú×ÔÈ»×éÖ¯Æ÷¹ÙÇøÓòÃâÒßÌØÕ÷Óë¼²²¡ÖØ´óÑо¿×¨Ïî¡¢¿Æ¼¼²¿¹ú¼ÒÖØµãÑз¢ÍýÏëÏîÄ¿ºÍ¹ú¼Ò¿Æ¼¼ÖØ´óרÏîµÈÖ§³ÖÏ£¬£¬ÍŶӷ¢Ã÷ÁËÏßÁ£Ì嶨λµÄ»·×´RNAÔÚ´úлÐÔÑ×Ö¢ÖÐʩչÖ÷Òª¹¦Ð§¡£¡£¡£NASH»¼ÕߵijÉÏËάϸ°ûÖÐÏßÁ£Ì嶨λµÄ»·×´RNAÏÔÖøÏµ÷£¬£¬Õë¶ÔÆäÖеÄÒ»¸ö»·×´RNA£¨SCAR£©¿ªÕ¹ÉîÈëÑо¿·¢Ã÷£¬£¬Ö¬·¾Ëáµ¼ÖµÄÄÚÖÊÍøÓ¦¼¤ÓÕµ¼CHOP±í´ïÉϵ÷£¬£¬CHOPÒÖÖÆPGC1¦Á£¬£¬´ËºóÕßµ÷¿ØSCAR±í´ï£¬£¬Òò´ËÖ¬Öʵ¼ÖÂSCARïÔÌ¡£¡£¡£SCARÔÚÏßÁ£ÌåÄÚͨ¹ýÁ¬ÏµmPTPµÄÑÇ»ùATP5B¶ø×èÖ¹Æä¿ª·Å£¬£¬ÒÖÖÆÏßÁ£ÌåROSºÍ³ÉÏËάϸ°û»î»¯¡£¡£¡£SCAR½éµ¼µÄÏßÁ£Ìåµ÷¿ØÍ¨Â·¹ØÓÚÃ÷È·NASH·¢²¡Àú³ÌÖиÎÔàµÄÏËά»¯µÄ±¬·¢ÆøÖÆÓÐÖ÷ÒªÒâÒå¡£¡£¡£ÁíÍ⣬£¬Ñо¿ÍŶÓÂÊÏȹ¹½¨°ÐÏòÏßÁ£Ìå»·×´RNAµÄÄÉÃ×µÝËÍϵͳ£¬£¬ÊµÏÖÔÚÌåÄÚÍâ¸ÉÔ¤ÏßÁ£Ìå»·×´RNA£¬£¬Îª°ÐÏòÏßÁ£ÌåÐźÅÖÎÁÆ´úлÐÔÃâÒß¼²²¡ÌṩÐÂ˼Ð÷¡£¡£¡£
Ëæ×ÅÉúÑÄ·½Ê½µÄ¸Ä±ä£¬£¬NAFLDÒѾȡ´ú²¡¶¾ÐÔ¸ÎÑ׳ÉΪĿ½ñÖ÷ÒªµÄÂýÐԸβ¡¡£¡£¡£´¿´âµÄNAFLDÊÇ¿ÉÄæµÄ£¬£¬µ«NASHÒÑÓиÎÏËά»¯µ¼ÖµÄÓÀÊÀÐÔ¸ÎÔಡ±ä¡£¡£¡£ÔõÑù¼õ»ººÍÄæ×ª¸ÎÔàÏËά»¯ÊÇNAFLD/NASHÑо¿µÄÖØµãºÍÄѵ㡣¡£¡£±¾Ñо¿Í¨¹ý¹¹½¨°ÐÏòÏßÁ£ÌåRNAµÄÄÉÃ×µÝËÍϵͳ£¬£¬Õ¹ÏÖÁËÏßÁ£Ì嶨λcircRNA¹¦Ð§£¬£¬ÆÊÎö¸ß֬ѹÁ¦µ¼ÖµÄÄÚÖÊÍø-ϸ°ûºË-ÏßÁ£Ìå¿çϸ°ûÆ÷ÐźÅÖáʧºâµ¼ÖÂÃâÒß´úлÐÔ¼²²¡Ï£ÍûµÄлúÖÆ¡£¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://doi.org/10.1016/j.cell.2020.08.009